WallStreetZenWallStreetZen

NYSE: SYK
Stryker Corp Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Stryker earnings were $2.9B for the trailing 12 months ending Mar 31, 2025, with -15.3% growth year over year. The latest SYK earnings report on Mar 31, 2025 announced Q1 2025 earnings of $654.0M, up 19.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, SYK reported annual earnings of $3.0B, with -5.4% growth. The next SYK earnings date is Jul 31, 2025.

SYK past earnings growth

How has SYK's earnings growth performed historically?

Company
-15.25%
Industry
50.78%
Market
33.86%
SYK's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
SYK's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
SYK's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

SYK earnings history

Current Revenue
$23.2B
Current Earnings
$2.9B
Current Profit Margin
12.3%
SYK's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

SYK Return on Equity

Current Company
14%
Current Industry
7.5%
Current Market
31.3%
SYK's Return on Equity (14%)... subscribe to Premium to read more.
High Return on Equity Performance

SYK undefined

Current Company
6.7%
Current Industry
8.7%
SYK is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when SYK announces earnings.

SYK undefined

Current Company
8.75%
Current Industry
9.1%
SYK has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

SYK vs Medical Device Stocks

TickerEBITDAEarningsY/Y EarningsEPS
SYK$3.76B$2.86B+5.31%$7.50
BSX$4.09B$2.03B-14.83%$1.38
MDT$9.19B$4.66B+0.33%$3.63
ABT$11.07B$13.50B+30.75%$7.72
EW$4.56B$4.18B+31.62%$7.03
View Top Medical Device Stocks

SYK earnings dates

Next earnings date
Jul 31, 2025

Stryker Earnings Reports & History FAQ

What were Stryker's earnings last quarter?

On SYK's earnings call on Invalid Date, Stryker (NYSE: SYK) reported Q1 2025 earnings per share (EPS) of $1.71, up 17.39% year over year. Total SYK earnings for the quarter were $654.00 million. In the same quarter last year, Stryker's earnings per share (EPS) was $2.07.

If you're new to stock investing, here's how to buy Stryker stock.

When does Stryker report earnings?

The next SYK earnings call is Invalid Date. Add SYK to your watchlist to be reminded of Stryker's next earnings date.

Is Stryker profitable or losing money?

As of the last Stryker earnings report, Stryker is currently profitable. Stryker's net profit (also called net income) for the twelve months ending Mar 31, 2025 was $2.86 billion, a 14.94% decrease year over year.

What was SYK's earnings growth in the past year?

As of Stryker's earnings date in Invalid Date, Stryker's earnings has grown -15.25% year over year. This is 66.04 percentage points lower than the US Medical Devices industry earnings growth rate of 50.78%. SYK earnings in the past year totalled $2.86 billion.

What are Stryker's earnings expectations?

The current EPS estimate for Stryker's earnings report in Invalid Date is $3.07.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.